1. Reciprocal fine-tuning of progesterone and prolactin-regulated gene expression in breast cancer cells
   Sean M. Holloran et al, 2020, Molecular and Cellular Endocrinology CrossRef
2. Nucleic acid amplification-based HER2 molecular detection for breast cancer
   Bugi Ratno Budiarto et al, 2019, Journal of Oncological Sciences CrossRef
3. Authors’ reply to the comment “Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism”
   Glauco Akelinghton Freire Vitiello et al, 2020, Breast Cancer Research and Treatment CrossRef
4. Association of TGF-β1 Polymorphisms with Breast Cancer Risk: A Meta-Analysis of Case–Control Studies
   B. Krishna et al, 2020, Cancers CrossRef
5. Improvement of a Predictive Model of Castration-Resistant Prostate Cancer: Functional Genetic Variants in TGFβ1 Signaling Pathway Modulation
   Ana L. Teixeira et al, 2013, PLoS ONE CrossRef
6. Association between the TGFBR2 G-875A Polymorphism and Cancer Risk: Evidence from a Meta-analysis
   Yong-Sheng Huang et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
7. HER2Ile655Val Polymorphism and Risk of Breast Cancer
   Tung Nguyen-Thanh et al, 2022, Genetic Polymorphisms - New Insights CrossRef
8. Updated Meta-analysis on HER2 Polymorphisms and Risk of Breast Cancer: Evidence from 32 Studies
   Wei Chen et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
9. Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes
   Glauco Akelinghton Freire Vitiello et al, 2019, Breast Cancer Research and Treatment CrossRef